The global autosamplers market size was valued at USD 1.1 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 6.9% from 2020 to 2027. An increasing number of research studies, as well as the increasing usage of automation in laboratories, are factors driving the market. Besides, the growing number of drug discovery, preclinical, and clinical trials due to the increasing efforts of the pharmaceutical and biopharmaceutical industry to develop effective products are anticipated to boost the market growth. The integration of autosampler in the laboratories is the modest and most cost-effective way to leverage high samples throughout the quick and direct gas analysis. Autosampler integration opens various applications of the technique for R&D and contract laboratories. There is a high demand for automation in the laboratory for numerous samples and workflows.
Autosamplers are not just limited to moving from sample to sample for analysis. They are designed to help in every aspect of the flexible and efficient workflow from reducing process order and transcription errors of sample information to complex cleaning and protection of samples for analysis. The intensive research being carried out in the pharmaceutical industry to develop a new drug is accelerating the demand for the product. Also, the government's support in the basic and early-stage research facilitates market growth. Advancements in chromatographs, mass spectrometers, electrophoresis systems, and other tools and instruments have led to progress in the drug discovery technologies.
Chromatography plays a significant role in pharmaceutical industries along with the chemical industry. The method is used in pharmaceutical industries to prepare very pure materials in huge quantities and to examine the purified compounds for trace contaminants. Hence, it creates a huge demand for autosamplers. Not only this, but the method also has importance in different departments such as biochemical processes, forensic science, and biotechnology industries.
Besides, to ensure that products pass definite standards, researchers, manufacturers, as well as developers, use numerous technical equipment and analytical methods, including liquid chromatography (LC), during the development process. LC is the workhorse of analytical laboratories of pharma companies for analysis of drug products, intermediates, bulk drug materials, impurities, and degradation products.
The autosampler systems segment dominated the autosamplers market and accounted for a revenue share of 63.6% in 2019. It is also anticipated to register the fastest CAGR of 7.0% over the forecast period. This is due to the increasing adoption of autosamplers due to various advantages it offers such as the reduction in errors, and high reproducibility.
Besides, increasing acceptance of autosampler for accuracy is also fuelling the market growth. Autosamplers save time, provide better reproducibility and improved speed as well as eliminates errors and provides higher accuracy. They are quite useful in handling the low volume of samples. The demand for autosamplers is rising due to advancements in the field of biological and chemical research.
The all-in-one-autosampler contributed 87.8% of the market as they combine the functions of an autosampler for liquid, headspace, and SPME in a single unit. It allows fast and easy switching from one application to another regardless if samples are processed in liquid, headspace, or SPME mode. The autosamplers deliver more precise results with greater throughput. It can extract both the volatile and non-volatile compounds in the liquid & headspace samples using variable vial penetration depth.
The pharmaceutical and biotechnological companies segment dominated the market in 2019 and accounted for a revenue share of 34.9%. This is attributed to the increasing R&D activities being carried out by those companies. In the pharmaceutical industry, all the manufactured products need to be of the highest quality to ensure the least risk to patients.
Robust Quality Assurance (QA), as well as Quality Control (QC) processes, are important for pharmaceutical firms to ensure the release of safe and effective products. Also, the increasing use of chromatography to separate chiral compounds, and to purify materials and analyze chemical compounds for trace contaminants is driving the demand for autosamplers.
North America dominated the market and accounted for 39.9% of the revenue share in 2019. The region is anticipated to exhibit the fastest growth rate over the forecast period. This is attributed to the huge investments in R&D and technological advancements in the analytical techniques leading to proper detection of proteins, metabolites, other complex molecules. In the region, the U.S. holds the maximum market share.
North America was followed by Europe with a revenue share of 23.3% in 2019. This is due to the increase in the acceptance of the chromatography techniques. Asia Pacific is anticipated to witness the fastest CAGR of 7.4% over the forecast period. This is attributed to the increasing number of biotechnology and pharmaceutical industries in the region which is likely to boost the adoption of autosamplers, thereby supporting market growth.
The market is characterized by the presence of well-established players in the market. Key companies are introducing new products with advanced features and technology that ease the operation of samples. For instance, FIAlab Instruments, INC.’s ASX-560 autosampler that features a corrosion-resistant coating on all the metal parts, metal-free liquid flow path, and can also withstand the harshest chemical environments while maintain surpassed accuracy. Besides, the HTA S.R.L.’s premium autosampler features SyringeID and Bar Code Reader (BCR). The BCR offers full and detailed tracking of sample information. The system also features a large and full-color touch screen interface, providing easier system accessibility as well as usability. Some of the prominent players in the autosamplers market include:
IQVIA
ICON Plc
Charles River Chemical industries
Pharmaceutical Product Development, LLC
Report Attribute |
Details |
Market Size value in 2020 |
USD 1.2 billion |
Revenue forecast in 2027 |
USD 1.8 billion |
Growth Rate |
CAGR of 6.9% from 2020 to 2027 |
Base year for estimation |
2019 |
Historical data |
2016 - 2018 |
Forecast period |
2020 - 2027 |
Quantitative units |
Revenue in USD million and CAGR from 2020 to 2027 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product type, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
The U.S.; Canada; The U.K.; Germany; France; Italy; Spain; China; India; Japan; Australia; South Korea; Mexico; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
Key companies profiled |
IQVIA; ICON Plc; Charles River Chemical industries; Pharmaceutical Product Development, LLC |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global autosamplers market report on the basis of product, end-use, and region:
Product Outlook (Revenue, USD Million, 2016 - 2027)
Autosampler Systems
GC Autosamplers
Liquid Autosamplers
Headspace Autosamplers
All-in-one Autosamplers
LC Autosamplers
Autosampler Accessories
Syringes & Needle
Vials
Septum
Others
End-use Outlook (Revenue, USD Million, 2016 - 2027)
Pharmaceutical & biotechnological companies
Chemical industries
CROs
Others
Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America
The U.S.
Canada
Europe
The U.K.
Germany
France
Italy
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global autosamplers market size was estimated at USD 1.1 billion in 2019 and is expected to reach USD 1.2 billion in 2020.
b. The global autosamplers market is expected to grow at a compound annual growth rate of 6.9% from 2020 to 2027 to reach USD 1.8 billion by 2027.
b. North America dominated the autosamplers market with a share of 39.8% in 2019. This is attributed to the huge investments in R&D, technological advancements in the analytical techniques leading to proper detection of proteins; metabolites; other complex molecules.
b. Some key players operating in the autosamplers market include PerkinElmer, Inc.; Shimadzu Corporation; Agilent Technologies Inc.; HTA S.R.L.; Waters Corporation; and Thermo Fisher Scientific, Inc.
b. Key factors that are driving the market growth include an increasing number of research studies, as well as the increasing use of automation in laboratories.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."